Drug Side Effects
Search
HER2 MUTANT NON-SMALL CELL LUNG CANCER
HER2 MUTANT NON-SMALL CELL LUNG CANCER
was reported 11 times
These drug classes are most commonly taken by patients reporting HER2 MUTANT NON-SMALL CELL LUNG CANCER:
#
Drug
Count
0
Folate Analog Metabolic Inhibitor [EPC]
6
1
Platinum-based Drug [EPC]
6
2
Vascular Endothelial Growth Factor Inhibitor [EPC]
6
3
Kinase Inhibitor [EPC]
5
4
HER2/neu Receptor Antagonist [EPC]
4
5
Microtubule Inhibitor [EPC]
2
6
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
7
Topoisomerase Inhibitor [EPC]
1
8
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]
1